KALV's three largest insider shareholders as of May 14, 2026 are Healthcare Capital Partners Iii, L.P. Venrock (TenPercentOwner, 5.09Mn shares), Healthcare Capital Partners Iii, L.P. Venrock (TenPercentOwner, 5.09Mn shares), Benjamin L Palleiko (Chief Executive Officer, 462.58K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Healthcare Capital Partners Iii, L.P. Venrock | - | 0 | 5,089,354 | 27 Mar, 2026 |
| Healthcare Capital Partners Iii, L.P. Venrock | - | 0 | 5,089,354 | 27 Mar, 2026 |
| Benjamin L Palleiko | Chief Executive Officer | 462,577 | 0 | 20 Apr, 2026 |
| Christopher Yea | Chief Development Officer | 226,701 | 0 | 24 Feb, 2026 |
| Christopher Yea | Chief Development Officer | 226,701 | 0 | 24 Feb, 2026 |
| Thomas Andrew Crockett | Ceo | 211,203 | 0 | 21 Feb, 2024 |
| Paul K. Audhya | Chief Medical Officer | 142,547 | 0 | 20 Apr, 2026 |
| Edward P. Feener | Chief Scientific Officer | 72,858 | 0 | 21 May, 2024 |
| Nicole Sweeny | Chief Commercial Officer | 51,391 | 0 | 20 Apr, 2026 |
| Nicole Sweeny | Chief Commercial Officer | 47,003 | 0 | 24 Feb, 2026 |
| Brian Piekos | Chief Financial Officer | 18,150 | 0 | 20 Apr, 2026 |
| Brian Piekos | Chief Financial Officer | 13,762 | 0 | 24 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Apr, 2026 | Benjamin L Palleiko | Common Stock | A | 20,312 | - | 472,127 | D | M |
| 16 Apr, 2026 | Brian Piekos | Common Stock | A | 6,250 | - | 20,012 | D | M |
| 16 Apr, 2026 | Nicole Sweeny | Common Stock | A | 6,250 | - | 53,253 | D | M |
| 16 Apr, 2026 | Paul K. Audhya | Common Stock | A | 6,250 | - | 145,233 | D | M |
| 17 Apr, 2026 | Benjamin L Palleiko | Common Stock | D | 9,550 | $20.22 | 462,577 | D | S |
| 17 Apr, 2026 | Nicole Sweeny | Common Stock | D | 1,862 | $20.22 | 51,391 | D | S |
| 17 Apr, 2026 | Brian Piekos | Common Stock | D | 1,862 | $20.22 | 18,150 | D | S |
| 17 Apr, 2026 | Paul K. Audhya | Common Stock | D | 2,686 | $20.22 | 142,547 | D | S |
| 16 Apr, 2026 | Nicole Sweeny | Restricted Stock Unit | D | 6,250 | $0.00 | 93,750 | D | M |
| 16 Apr, 2026 | Brian Piekos | Restricted Stock Unit | D | 6,250 | $0.00 | 93,750 | D | M |
| 16 Apr, 2026 | Paul K. Audhya | Restricted Stock Unit | D | 6,250 | $0.00 | 93,750 | D | M |
| 16 Apr, 2026 | Benjamin L Palleiko | Restricted Stock Unit | D | 20,312 | $0.00 | 304,688 | D | M |
| 25 Mar, 2026 | Healthcare Capital Partners Iii, L.P. Venrock | Common Stock | D | 174,485 | $16.95 | 5,129,500 | I | S |
| 25 Mar, 2026 | Healthcare Capital Partners Iii, L.P. Venrock | Common Stock | D | 174,485 | $16.95 | 5,129,500 | I | S |
| 25 Mar, 2026 | Healthcare Capital Partners Iii, L.P. Venrock | Common Stock | D | 160 | $17.53 | 5,129,340 | I | S |
| 25 Mar, 2026 | Healthcare Capital Partners Iii, L.P. Venrock | Common Stock | D | 160 | $17.53 | 5,129,340 | I | S |
| 26 Mar, 2026 | Healthcare Capital Partners Iii, L.P. Venrock | Common Stock | D | 21,386 | $17.76 | 5,107,954 | I | S |
| 26 Mar, 2026 | Healthcare Capital Partners Iii, L.P. Venrock | Common Stock | D | 21,386 | $17.76 | 5,107,954 | I | S |
| 26 Mar, 2026 | Healthcare Capital Partners Iii, L.P. Venrock | Common Stock | D | 15,417 | $18.82 | 5,092,537 | I | S |
| 26 Mar, 2026 | Healthcare Capital Partners Iii, L.P. Venrock | Common Stock | D | 15,417 | $18.82 | 5,092,537 | I | S |